neobookRx
DrugsLevel 4 LocalisationS4INH · ACCEML

Salmeterol

Long-acting selective beta-2 agonistBronchodilator

Indications

Registered South African indications:

  • Asthma
  • Chronic obstructive pulmonary disease

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients

Cautions

  • Pregnancy
  • Breastfeeding
  • Hepatic impairment 
  • Acute asthma
  • Cardiovascular disease
  • Thyrotoxicosis
  • Diabetes mellitus
  • Hypokalaemia
  • Lactose intolerance
  • Concomitant use of systemic ketoconazole
  • Patients with cognitive impairment (poor inhaler technique)

Adult dosage

Forms avail. in SA and covered in this monograph: acc, inh

Chronic asthma (Additional agent required)
Chronic obstructive pulmonary disease

  • Inhaled (acc, inh): 50-100μg, 12hrly; Max: 200μg/24hrs

Not to be used as monotherapy in asthma (see additional prescribing points)

Paediatric dosage

Paed. forms avail. in SA and covered in this monograph: acc, inh

Chronic asthma (Additional agent required)

Younger than 4 years

  • Not established for use 

Older than 4 years

  • Inhaled (acc, inh): 50μg, 12hrly; Max: 100μg/24hrs

Not to be used as monotherapy in asthma (see additional prescribing points)

Special populations

Pregnancy

  • Caution
  • A moderate amount of clinical data on pregnant women (between 300 to 1000 pregnancy outcomes) indicate no malformative or foetal/ neonatal toxicity of salmeterol. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity with the exception of evidence of some harmful effects on the foetus at very high dose levels. As a precautionary measure, it is preferable to avoid the use of salmeterol during pregnancy

Breastfeeding

  • Caution
  • Available pharmacodynamic/toxicological data in animals have shown excretion of salmeterol in milk. A risk to the suckling child cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from salmeterol therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Central Nervous System Disorders

  • Nervousness
  • Insomnia
  • Headache 
  • Tremor 
  • Dizziness

Cardiovascular Disorders

  • Palpitations 
  • Tachycardia
  • Arrhythmias
  • Chest pain

Respiratory Disorders

  • Oropharyngeal irritation
  • Paradoxical bronchospasm

Gastrointestinal Disorders

  • Nausea

Endocrine and Metabolic Disorders

  • Hypokalaemia
  • Hyperglycaemia

Musculoskeletal Disorders

  • Muscle cramps
  • Arthralgia

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity reactions
  • Anaphylactic reactions
  • Anaphylactic shock

Interactions

  • Beta blockers
  • Xanthine derivatives
  • Steroids
  • Diuretics
  • CYP3A4 inhibitors
  • CYP3A4 inhibitors

Monitoring

None routine. Specific cases may require

  • Serum potassium
  • Blood glucose
  • Vital signs

Prescribing points

  • Patients with asthma should never be on a long-acting beta agonist (such as Salmeterol or Formoterol) without an inhaled corticosteroid
  • Salmeterol Accuhaler should be used regularly. The full benefits of treatment will be apparent after several doses of the drug

Mechanism of action

Salmeterol is a selective long-acting beta-2 adrenoceptor agonist with a long side chain which binds to the exo-site of the receptors in the lungs and on bronchiolar smooth muscle. This causes relaxation of bronchial smooth muscle, bronchodilation and increased bronchial airflow.

Dosage forms

  • Inhaler
  • Accuhaler

Formulation

Inhaler 25μg 

  • Serevent Inhaler CFC-Free (Aspen) originator

Accuhaler 50μg 

  • Serevent Accuhaler (GSK) originator

COMBINATION PREPARATIONS

Salmeterol/ Fluticasone propionate

Inhaler 25μg/50μg

  • Sereflo 25/50 Hfa (Cipla)
  • Foxair inhaler (Aspen) originator
  • Seretide CFC inhaler (GSK)

Inhaler 25μg/125μg

  • Sereflo 25/125 Hfa (Cipla)
  • Foxair inhaler (Aspen) originator
  • Seretide CFC inhaler (GSK)

Inhaler 25μg/250μg

  • Sereflo 25/250 Hfa (Cipla)
  • Foxair inhaler (Aspen) originator
  • Seretide CFC inhaler (GSK)

Accuhaler 50μg/100μg

  • Foxair Accuhaler (Aspen)
  • Seretide Accuhaler (GSK)

Accuhaler 50μg/250μg

  • Foxair Accuhaler (Aspen)
  • Seretide Accuhaler (GSK)

Accuhaler 50μg/500μg

  • Foxair Accuhaler (Aspen)
  • Seretide Accuhaler (GSK)

References

1. SAMF_12th Edition_Pge 550 2. SmPC: Serevent Accuhaler, GlaxoSmithKline UK: Last updated on eMC: 02 Oct 2018; Downloaded online; 25 Nov 2018 [https://www.medicines.org.uk/emc/medicine/91] 3. https://drive.google.com/drive/folders/0B0xnChtF7vdua0lHaFhJbmd1cUk (15/09/2006_Aspen_Serevent_inh 25mcg) 4. https://drive.google.com/drive/folders/0B0xnChtF7vdua0lHaFhJbmd1cUk (18/08/1995_GSK_Serevent_acc 50mcg) 5. SmPC: Serevent Evohaler, GlaxoSmithKline UK: Last updated on eMC: 02 Oct 2018; Downloaded online; 25 Nov 2018 [https://www.medicines.org.uk/emc/medicine/17201] 6. U2D: Salmeterol: Drug information; Uptodate; Downloaded online; 25 Nov 2018 https://www.uptodate.com/contents/salmeterol-drug-information?search=salmeterol&source=panel_search_result&selectedTitle=1~80&usage_type=panel&kp_tab=drug_general&display_rank=1 7. NAPOS The Drug Database for Acute Porphyria: Salmeterol; Accessed online; 20 Nov 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=R03AC12&l=gbr] 8. South African Institute for Drug-Free Sport: Serevent; Accessed online; 20 Nov 2018 [http://www.drugfreesport.org.za/online-medication-check/ 9. SmPC: Serevent Accuhaler, GlaxoSmithKline UK: Last updated on eMC: 29 Nov 2019; Downloaded online; 8 Apr 2020 [https://drive.google.com/drive/folders/1nHE7j17r0pBDedsx5zTrNNqqzGms9MdD]

Brands & products

17 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

inhalerGeneric· 6 products

from R2.01/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Sereflo 25/50 hfa synchrobreathe 120 dos25 µg120S4R241.69R2.01R91.70721412001
Sereflo 25/125 hfa synchrobreathe 120 do25 µg120S4R314.19R2.62R111.64721413001
Sereflo 25/250 hfa synchrobreathe 120 do25 µg120S4R410.63R3.42R138.17721414001
Foxair 25/50 120 dose50 mcg120S4R414.59R3.45R139.26715752001
Foxair 25/125 120dose125 mcg120S4R532.88R4.44R162.86715753001
Serevent cfc-free 120dose25 mcg120S2R797.40R6.64R201.77708289001

solutionGeneric· 1 product

from R2.66/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Keppra50 mcg300S3R796.85R2.66R201.69714166001

AccGeneric· 8 products

from R5.71/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Airflusal Forspiro 50/250250 mcg60S4R342.76R5.71R119.503004879001
Casorol Casometer 50/250 Μg250 mcg60S4R363.67R6.06R125.263005769001
Foxair accuhaler 60 dose 50/100100 mcg60S4R467.02R7.78R153.69715009001
Airflusal Forspiro 50/500500 mcg60S4R505.11R8.42R158.773004880001
Casorol Casometer 50/500 Μg500 mcg60S4R532.69R8.88R162.833005772001
Foxair accuhaler 60 dose 50/250250 mcg60S4R533.66R8.89R162.97715008001
Foxair accuhaler 60 dose 50/500500 mcg60S4R720.05R12.00R190.39715007001
Serevent accuhaler 60dose50 mcg60S4R797.40R13.29R201.77818496002

suspensionGeneric· 1 product

from R25.71/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Wellvone50 mcg210S4R5398.70R25.71R509.26864587008

KitGeneric· 1 product

from R132.75/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Relenza25 mcg5S4R663.77R132.75R182.11888609002
Trade names (1)
  • Serevent

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Interacts with 8 known drugs

Check against other drugs →

Cited in 12 documents

NeoHealth® ID 16460 · updated 11/25/2024